Apple rolls out digital subscription service | February 15, 2011 12:14 PM ET | NEW YORK (Reuters) - Apple Inc is launching a long-awaited subscription service for magazines, newspapers, videos and music -- a move that could dent the fortunes of successful services such as Netflix and Hulu. | Full Article | Samsung says low-end phones not for profit | February 15, 2011 12:12 PM ET | BARCELONA, Spain (Reuters) - Samsung Electronics hopes to attract new consumers to its brand with cheap, low-end phones that are not necessarily focused on making profit for the group, a senior executive said. | Full Article | America Movil eyes Polkomtel | February 15, 2011 10:16 AM ET | BARCELONA (Reuters) - Carlos Slim's America Movil may join the 4 billion euro Polkomtel auction, switching its focus away from Serbia, the company's CEO Daniel Hajj told Reuters at a telecoms trade fair on Tuesday. | Full Article | | | BUSINESS NEWS | Deutsche Boerse unveils NYSE mega-exchange deal | February 15, 2011 04:27 PM ET | FRANKFURT/NEW YORK (Reuters) - Deutsche Boerse will take over NYSE Euronext to create the world's largest exchange operator in a deal worth $10.2 billion, but the exchanges dodged key questions that could threaten the accord. | Full Article | Dell margins top Street view | February 15, 2011 04:35 PM ET | SAN FRANCISCO (Reuters) - Dell Inc posted much better-than-expected profit and margins, as large and small businesses continued to spend on new technology hardware. | Full Article | LSE close hit by technical glitch | February 15, 2011 01:26 PM ET | LONDON (Reuters) - The London Stock Exchange failed to stop trading Tuesday as scheduled -- one day after completing a major system upgrade -- causing confusion among its clients, who blamed a technical problem. The LSE, which ends normal trading at 1630 GMT before starting its closing auction, conceded on its website that normal trading did not cease until 42 seconds after the official close at 1630. | Full Article | Sanofi to buy Genzyme for about $19 billion: sources | February 15, 2011 03:40 PM ET | BOSTON/PHILADELPHIA (Reuters) - Sanofi-Aventis SA has reached an agreement in principle to buy Genzyme Corp for about $19 billion in cash plus future payments based on the performance of an experimental Genzyme drug, according to two sources with knowledge of the talks. | Full Article | | | US TOP NEWS | | | | RELATED VIDEO | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today. | | Your daily briefing on the latest tech developments from around the world from Reuters expert tech correspondents. Register Today. | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day.. Register Today. | | » MORE NEWSLETTERS | | ODDLY ENOUGH | | | |
没有评论:
发表评论